Sirona Medical Technologies, Inc. is a venture-backed cardiac electrophysiology company developing combined focal mapping and ablation catheters for the treatment of cardiac arrhythmias. Sirona’s innovative technology is intended to provide a safer, more effective and more efficient ablation solution by delivering focused Pulsed Field (PF) or Radio Frequency (RF) electrical energy to the target tissue. Sirona’s innovative rotation mechanism allows precise placement of the catheter array to ensure optimal lesion overlap for maximum lesion durability.
Sirona's mission is to apply advanced concepts of physics and engineering to create transformational products which improve the safety, efficacy and speed of cardiac electrophysiology procedures.
Our vision is to be the unmatched leader in developing innovative products for the diagnosis and treatment of cardiac electrophysiology disorders. Our goal is for these products to dramatically improve the quality of care and health outcomes for the patients we serve.